NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance

Maria Rita Emma(Istituto di Biomedicina e di Immunologia Molecolare Alberto Monroy), Melchiorre Cervello(Istituto di Biomedicina e di Immunologia Molecolare Alberto Monroy)
Cell Death and Disease
June 23, 2016
10.1038/cddis.2016.175
Cited by 141

Related Papers

Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation
|International Journal of Oncology|2017|94
Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer Cells
|PLoS ONE|2013|50
Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells
|Cell Death and Disease|2018|47